Associate professor from Liaocheng University, China
Min Hong is an accomplished Associate Professor at Liaocheng University, China, with a strong background in analytical and organic chemistry, specializing in nanotechnology applications for targeted anti-cancer therapies. Over her career, she has focused on designing and synthesizing innovative nano prodrugs and fluorinated liposome nanocarriers to improve cancer treatment efficacy. Min’s research exhibits a consistent trajectory of high-impact scientific contributions, demonstrated by numerous publications in leading international journals. Her work bridges fundamental chemistry and applied biomedical research, making significant strides in drug delivery systems. Min Hong’s expertise is further enriched by her international exposure as a visiting scholar at the University of Florida, enhancing her collaborative and cross-disciplinary capabilities. Recognized by prestigious regional scientific awards, she continues to advance the frontier of cancer nanomedicine. Her sustained research productivity, coupled with her dedication to academic growth and innovation, positions her as a key figure in her field, making her a strong candidate for the Best Researcher Award.
Professional profile
Education
Min Hong’s academic journey began with a Bachelor’s degree in Chemistry from Liaocheng University in 2003. She then pursued a Master’s degree in Organic Chemistry at the same university, completing it in 2006 under the guidance of advisor Handong Yin. Continuing her specialization, she earned a Ph.D. in Analytical Chemistry from Nanjing University in 2009, working with advisor Jin Zhu. This strong foundation in both organic and analytical chemistry underpins her research on drug delivery and nanomedicine. To further expand her expertise and foster international collaboration, Min Hong undertook a visiting scholar position at the University of Florida in the USA from 2018 to 2019. This experience exposed her to advanced research methodologies and global perspectives in chemistry and pharmaceutical sciences, enriching her skill set and research vision. Her education path reflects a rigorous, interdisciplinary approach, preparing her for innovative contributions in targeted cancer therapy research.
Professional Experience
Min Hong has steadily progressed through academic roles, reflecting her growth and leadership in research. From 2009 to 2013, she served as a lecturer at Liaocheng University, where she began establishing her independent research agenda. Following this, she enhanced her expertise during a postdoctoral fellowship at Shandong Normal University from 2013 to 2016, working under Bo Tang. Since 2016, she has held the position of Associate Professor at Liaocheng University, leading research projects focused on nanotechnology-based anticancer drug delivery systems. Her professional experience spans teaching, research, and mentoring students, combining theoretical knowledge with practical laboratory skills. She has also collaborated extensively within her institution and internationally, contributing to joint publications and multi-disciplinary projects. Her academic appointments demonstrate a sustained commitment to advancing science through both education and innovative research, positioning her as a respected faculty member and emerging leader in her field.
Research Interests
Min Hong’s primary research interests lie in the design and synthesis of nanomedicine platforms for targeted cancer therapy. Specifically, she focuses on camptothecin nano prodrugs, which offer enhanced selectivity and reduced side effects in anticancer treatment. Additionally, she works on constructing fluorinated liposome nanocarrier systems that improve drug stability, delivery efficiency, and tumor targeting capabilities. These interests reflect a deep engagement with chemical engineering, pharmaceutical chemistry, and nanotechnology to develop next-generation therapeutic agents. Her interdisciplinary approach integrates organic synthesis, analytical techniques, and biological evaluation to optimize drug delivery and anticancer efficacy. Min Hong’s work also explores mechanisms such as microRNA-responsive drug release and multi-pathway cancer cell targeting, highlighting her commitment to advancing precision medicine. Her research contributes to both fundamental scientific knowledge and practical solutions for cancer treatment challenges, positioning her at the forefront of nanomedicine innovation.
Research Skills
Min Hong possesses a comprehensive set of research skills that support her advanced work in nanomedicine and chemical synthesis. She is proficient in organic synthesis techniques, enabling the development of complex nano prodrug molecules. Her expertise extends to the preparation and functionalization of liposome nanocarriers, including fluorination strategies for enhanced drug delivery. She employs advanced analytical methods such as fluorescence imaging, SALDI-MS, and cytotoxicity assays to characterize and evaluate her synthesized compounds. Min Hong is skilled in in vitro biological evaluation techniques to assess anticancer activity and drug targeting efficacy. Her multidisciplinary skill set also includes nanoparticle assembly, molecular imaging, and enzyme-free signal amplification methods. Additionally, she demonstrates strong capabilities in scientific writing and publishing, as evidenced by her extensive publication record. These technical and analytical competencies allow her to conduct rigorous and innovative research in targeted drug delivery systems, fostering impactful contributions to cancer therapeutics.
Awards and Honors
Min Hong has received several awards and honors recognizing her academic and research excellence. In 2024, she was awarded the Second Prize by the Shandong Chemical and Chemical Society for Science and Technology, highlighting her significant contributions to chemical research in her region. Earlier in her career, she was recognized as an Outstanding Graduate of Shandong Province in 2006, reflecting early promise and academic achievement. She also earned the Excellent Master’s Degree Thesis Award from Shandong Province and the Excellent Doctoral Degree Thesis Award from Nanjing University in 2006 and 2009, respectively. These honors attest to her consistent academic excellence from graduate education through her professional career. Such recognition underscores her dedication to quality research and her impact on the chemical and pharmaceutical sciences community. These awards validate her role as a leading researcher and support her candidacy for further distinctions such as the Best Researcher Award.
Conclusion
Min Hong is a highly qualified and accomplished researcher whose work exemplifies innovation and impact in targeted anti-cancer nanomedicine. Her academic credentials, research focus, and extensive publication record demonstrate her capability to lead significant advancements in drug delivery technologies. Recognized by prestigious awards and supported by international experience, she has made important contributions to the understanding and development of nano prodrugs and liposome-based therapies. While her achievements are already commendable, further highlighting her leadership in securing research funding, mentorship roles, and translational impacts could enhance her profile. Overall, Min Hong’s sustained excellence, innovative approach, and scientific rigor make her a deserving candidate for the Best Researcher Award, reflecting both her current achievements and her potential for future contributions to biomedical research.
Publications Top Notes
-
Title: Portable arginine sensing on polyvinyl alcohol membrane based on aggregation-induced emission enhancement of carbon dots
Authors: Yang, Dou; Shao, Tong; Li, Peng; Li, Rui; Yue, Qiaoli
Journal: Talanta
Year: 2025
-
Title: Construction of folic acid modified fluoro-liposomes for oral delivery of erastin to achieve targeted anti-tumor therapy
Authors: Hong, Min; Liu, Xiaoyan; Ji, Qinghong; Yue, Qiaoli; Cheng, Shuang
Journal: Drug Delivery and Translational Research
Year: 2025
Citations: 1
-
Title: Simultaneous Down-Regulation of Intracellular MicroRNA-21 and hTERT mRNA Using AS1411-Functionalized Gold Nanoprobes to Achieve Targeted Anti-Tumor Therapy
Authors: Ji, Qinghong; Yang, Qiangqiang; Ou, Mengyao; Hong, Min
Journal: Nanomaterials
Year: 2024
-
Title: Investigation of in vitro antiviral and antimicrobial activities of cepharanthine-luteolin and their interaction with pepsin by multispectral and molecular docking methods
Authors: Zhang, Qian; Li, Mingyuan; Liu, Cui; Liu, Jie; Hong, Min
Journal: Journal of Molecular Liquids
Year: 2024
Citations: 1
-
Title: Application of carbon dots synthesized with amino acid as precursor in the detection of phloroglucinol
Authors: Wang, Min; Hou, Aiying; Yang, Dou; Hong, Min; Yue, Qiaoli
Journal: Microchemical Journal
Year: 2024
Citations: 3
-
Title: Portable sensing methods based on carbon dots for food analysis (Review)
Authors: Wang, Min; Wang, Lijun; Hou, Aiying; Li, Chenzhong; Yue, Qiaoli
Year: 2024
Citations: 1
-
Title: Synthesis and biological evaluation of folic acid-rotenol conjugate as a potent targeted anticancer prodrug
Authors: Hong, Min; Wang, Juan; Chen, Haobin; Li, Lei; Cheng, Shuang
Journal: European Journal of Pharmacology
Year: 2024
Citations: 1
-
Title: Construction of l-Carnitine-Modified TPGS Micelles to Achieve Oral Delivery of Camptothecin and Targeted Anticancer Effects
Authors: Chen, Haobin; Hong, Min; Liu, Xiaoyan; Cheng, Shuang; Li, Chenzhong
Journal: ACS Applied Polymer Materials
Year: 2024
Citations: 1
-
Title: N-doped carbon dots for the determination of Al³⁺ and Fe³⁺ using aggregation-induced emission
Authors: Yang, Dou; Shao, Tong; Wang, Xiaoshuang; Li, Chenzhong; Yue, Qiaoli
Journal: Mikrochimica Acta
Year: 2024
Citations: 5
-
Title: Carbonized polymer dots for the sensitive and selective analysis of chlortetracycline based on the aggregation induced emission
Authors: Shao, Tong; Wang, Xiaoshuang; Guan, Rentian; Hong, Min; Yue, Qiaoli
Journal: New Journal of Chemistry
Year: 2023
Citations: 4